Quantification of methylphenidate in rat, rabbit and dog plasma using a chiral liquid-chromatography/tandem mass spectrometry method - Application to toxicokinetic studies

被引:12
作者
Bakhtiar, R [1 ]
Ramos, L [1 ]
Tse, FLS [1 ]
机构
[1] Novartis Inst Biomed Res, E Hanover, NJ 07936 USA
关键词
mass spectrometry (MS); Ritalin (R); toxicokinetic; enantioselective; atmospheric pressure chemical ionization; methylphenidate (MPH); vancomycin column;
D O I
10.1016/S0003-2670(02)00725-0
中图分类号
O65 [分析化学];
学科分类号
070302 [分析化学]; 081704 [应用化学];
摘要
Ritalin or methylphenidate (MPH) is prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. The present report concerns the development and validation of an enantioselective reversed-phase liquid-chromatography/tandem mass spectrometry (LC/MS/MS) method, which was used in the determination of plasma concentrations of D- and L-antipodes of MPH in toxicokinetic (TK) studies in rats, rabbits, and dogs, following repeated daily oral dosing for up to 13 weeks. The sample processing involved the addition of sodium bicarbonate (1.0 M, pH 10) to plasma followed by liquid-liquid extraction using cyclohexane. Vancomycin, an amphoteric macrocyclic glycopeptide, produced by Streptomyces orientalis proved to be a rugged chiral selector for LC/MS/MS analysis of MPH. In all species, MPH appeared to be rapidly absorbed (T-max = 0.5-2h). Generally, the plasma exposure (area under the plasma concentration-time curve (AUC) and C-max)) of MPH was over-proportional to the dose. No differences in TK of MPH were observed between male and female dogs whereas in rats, females generally exhibited a slightly higher level of exposure than males. No unusual level of accumulation of MPH inconsistent with previously reported half-life (T-1/2 similar to 2.5h) of this compound was observed. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:261 / 272
页数:12
相关论文
共 33 条
[1]
NONLINEAR KINETICS OF THREO-METHYLPHENIDATE ENANTIOMERS IN A PATIENT WITH NARCOLEPSY AND IN HEALTHY-VOLUNTEERS [J].
AOYAMA, T ;
KOTAKI, H ;
SASAKI, T ;
SAWADA, Y ;
HONDA, Y ;
IGA, T .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 44 (01) :79-84
[2]
Bakhtiar R, 2001, CHIRALITY, V13, P63, DOI 10.1002/1520-636X(2001)13:2<63::AID-CHIR1000>3.0.CO
[3]
2-5
[5]
Mass spectrometry in the clinical laboratory [J].
Chace, DH .
CHEMICAL REVIEWS, 2001, 101 (02) :445-477
[6]
Challman TD, 2000, MAYO CLIN PROC, V75, P711
[7]
Treatment of attention-deficit-hyperactivity disorder [J].
Elia, J ;
Ambrosini, PJ ;
Rapoport, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (10) :780-788
[8]
DRUG-TREATMENT FOR HYPERACTIVE-CHILDREN - THERAPEUTIC GUIDELINES [J].
ELIA, J .
DRUGS, 1993, 46 (05) :863-871
[9]
Electrospray and tandem mass spectrometry in biochemistry [J].
Griffiths, WJ ;
Jonsson, AP ;
Liu, SY ;
Rai, DK ;
Wang, YQ .
BIOCHEMICAL JOURNAL, 2001, 355 :545-561
[10]
Transformations in pharmaceutical research and development, driven by innovations in multidimensional mass spectrometry-based technologies [J].
Hoke, SH ;
Morand, KL ;
Greis, KD ;
Baker, TR ;
Harbol, KL ;
Dobson, RLM .
INTERNATIONAL JOURNAL OF MASS SPECTROMETRY, 2001, 212 (1-3) :135-196